Shoujun Yuan

986 total citations
38 papers, 812 citations indexed

About

Shoujun Yuan is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Shoujun Yuan has authored 38 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 10 papers in Oncology and 8 papers in Immunology. Recurrent topics in Shoujun Yuan's work include Angiogenesis and VEGF in Cancer (4 papers), Synthesis and biological activity (3 papers) and Cancer-related Molecular Pathways (3 papers). Shoujun Yuan is often cited by papers focused on Angiogenesis and VEGF in Cancer (4 papers), Synthesis and biological activity (3 papers) and Cancer-related Molecular Pathways (3 papers). Shoujun Yuan collaborates with scholars based in China, Czechia and Egypt. Shoujun Yuan's co-authors include Dexuan Yang, Huadong Zhang, Linna Li, Zhixian Sun, Pan Zou, Xin Yang, Xingchen Zhai, Chengwang Xu, Jing Wang and Wanjun Guo and has published in prestigious journals such as PLoS ONE, Journal of Agricultural and Food Chemistry and International Journal of Molecular Sciences.

In The Last Decade

Shoujun Yuan

38 papers receiving 805 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shoujun Yuan China 17 466 132 125 121 116 38 812
Maria Rita Emma Italy 18 456 1.0× 116 0.9× 104 0.8× 76 0.6× 152 1.3× 25 846
Guohui Cui China 17 628 1.3× 173 1.3× 88 0.7× 69 0.6× 119 1.0× 72 1.1k
Luigi Quintieri Italy 20 461 1.0× 262 2.0× 118 0.9× 81 0.7× 73 0.6× 53 1.0k
Bijesh Kumar Biswal India 18 541 1.2× 140 1.1× 162 1.3× 67 0.6× 144 1.2× 49 966
Adrianna Gielecińska Poland 13 403 0.9× 162 1.2× 102 0.8× 88 0.7× 124 1.1× 21 846
Qunyou Tan China 20 438 0.9× 122 0.9× 140 1.1× 170 1.4× 79 0.7× 48 1.0k
Giuseppa Augello Italy 21 529 1.1× 165 1.3× 140 1.1× 57 0.5× 192 1.7× 35 1.0k
Sonia Aroui Tunisia 14 452 1.0× 91 0.7× 52 0.4× 112 0.9× 63 0.5× 19 717
Samil Jung South Korea 17 497 1.1× 88 0.7× 63 0.5× 66 0.5× 83 0.7× 34 877
Dipon Das India 22 561 1.2× 297 2.3× 178 1.4× 61 0.5× 125 1.1× 31 1.1k

Countries citing papers authored by Shoujun Yuan

Since Specialization
Citations

This map shows the geographic impact of Shoujun Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoujun Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoujun Yuan more than expected).

Fields of papers citing papers by Shoujun Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoujun Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoujun Yuan. The network helps show where Shoujun Yuan may publish in the future.

Co-authorship network of co-authors of Shoujun Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Shoujun Yuan. A scholar is included among the top collaborators of Shoujun Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoujun Yuan. Shoujun Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deng, Mengyan, Linna Li, Jianchun Zhao, Shoujun Yuan, & Wenbao Li. (2018). Antitumor activity of the microtubule inhibitor MBRI-001 against human hepatocellular carcinoma as monotherapy or in combination with sorafenib. Cancer Chemotherapy and Pharmacology. 81(5). 853–862. 12 indexed citations
2.
Zhai, Xingchen, Shoujun Yuan, Xin Yang, et al.. (2018). Growth-inhibition of S180 residual-tumor by combination of cyclophosphamide and chitosan oligosaccharides in vivo. Life Sciences. 202. 21–27. 13 indexed citations
3.
Li, Linna, Ning Su, Ting Zhou, et al.. (2018). Mixed lineage kinase ZAK promotes epithelial–mesenchymal transition in cancer progression. Cell Death and Disease. 9(2). 143–143. 13 indexed citations
4.
Guan, Fang, Rui Ding, Qi Zhang, et al.. (2017). WX-132-18B, a novel microtubule inhibitor, exhibits promising anti-tumor effects. Oncotarget. 8(42). 71782–71796. 28 indexed citations
5.
Wang, Ying, Shoujun Yuan, Linna Li, et al.. (2017). Novel proapoptotic agent SM-1 enhances the inhibitory effect of 5-fluorouracil on colorectal cancer cells in vitro and in vivo. Oncology Letters. 13(6). 4762–4768. 5 indexed citations
6.
Xuan, Zixue, Su Zhang, Shoujun Yuan, Wei Wang, & Jia Yu. (2016). Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis. World Journal of Surgical Oncology. 14(1). 237–237. 11 indexed citations
7.
Chen, Pingping, et al.. (2016). Removal of nutrient elements and estrogens in urban tail water by constructed wetland. 10(11). 6512. 2 indexed citations
8.
Zou, Pan, Xin Yang, Yanxin Zhang, et al.. (2016). Antitumor Effects of Orally and Intraperitoneally Administered Chitosan Oligosaccharides (COSs) on S180‐Bearing/Residual Mouse. Journal of Food Science. 81(12). H3035–H3042. 27 indexed citations
9.
Zhang, Qi, et al.. (2016). Preclinical pharmacodynamic evaluation of antibiotic nitroxoline for anticancer drug repurposing. Oncology Letters. 11(5). 3265–3272. 28 indexed citations
10.
Wang, Xiao Feng, Emika Ohkoshi, Masuo Goto, et al.. (2016). Synthesis, biological evaluation, and physicochemical property assessment of 4-substituted 2-phenylaminoquinazolines as Mer tyrosine kinase inhibitors. Bioorganic & Medicinal Chemistry. 24(13). 3083–3092. 6 indexed citations
11.
Li, Linna, Dexuan Yang, Jia Na, et al.. (2014). Anticancer activity of tuftsin-derived T peptide in postoperative residual tumors. Anti-Cancer Drugs. 25(8). 857–867. 12 indexed citations
12.
Zhang, Hui, Wei Gong, Zhiyuan Wang, et al.. (2014). Preparation, Characterization, and Pharmacodynamics of Thermosensitive Liposomes Containing Docetaxel. Journal of Pharmaceutical Sciences. 103(7). 2177–2183. 34 indexed citations
13.
Wang, Xiao Feng, Fang Guan, Emika Ohkoshi, et al.. (2014). Optimization of 4-(N-Cycloamino)phenylquinazolines as a Novel Class of Tubulin-Polymerization Inhibitors Targeting the Colchicine Site. Journal of Medicinal Chemistry. 57(4). 1390–1402. 61 indexed citations
14.
Zhan, Wenhu, et al.. (2012). Design, synthesis and antitumor activities of novel bis-aryl ureas derivatives as Raf kinase inhibitors. Bioorganic & Medicinal Chemistry. 20(14). 4323–4329. 22 indexed citations
15.
Zhao, Yan, Xin Ge, Shoujun Yuan, et al.. (2011). Production and Radioprotective Effects of Pyrroloquinoline Quinone. International Journal of Molecular Sciences. 12(12). 8913–8923. 31 indexed citations
16.
Yuan, Shoujun. (2011). Evaluation of the Inhibitory Effects of Human Endostadin Peptide on Postsurgical Residual Tumors Growth in Mice/Nude Mice. Zhōnghuá yàoxué zázhì. 1 indexed citations
17.
Zhang, Huadong, et al.. (2010). Down‐regulation of some miRNAs by degrading their precursors contributes to anti‐cancer effect of mistletoe lectin‐I. British Journal of Pharmacology. 162(2). 349–364. 35 indexed citations
18.
Chen, Junhui, Shaobin Wang, En‐Min Li, et al.. (2008). [Inhibitory effect of Oridonin injection on heterotransplanted gastric adenocarcinoma in nude mice and its mechanism].. PubMed. 30(2). 89–92. 5 indexed citations
19.
Zhang, Huadong, et al.. (2007). Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt/β‐catenin pathway. International Journal of Cancer. 121(6). 1360–1365. 103 indexed citations
20.
Yuan, Shoujun, et al.. (2006). Radiation-induced reduction of chromium(VI) in aqueous solution by γ-irradiation in a laboratory-scale. Journal of Environmental Sciences. 18(2). 254–258. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026